Stock Information
Compass Therapeutics Inc. (CMPX)
Ticker Symbol: CMPX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $407.00 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.3132
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -29.94%
Latest News
-
Compass Therapeutics Abstract Accepted For Oral Presentation At Upcoming European Society For Medical Oncology Congress
Fri, Jul 17, 2026 10:47 AM
-
Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity
Wed, Jul 15, 2026 2:31 PM
Key Financials
Financial data not available
